CRP and inflammatory bowel disease: Markers based on systemic inflammation, such as C-reactive protein (CRP), TNFα, interleukin-6, or white blood cell (WBC) count have been reported to be useful in predicting the prognosis in patients with inflammatory disease including inflammatory bowel disease [6].